Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-04-000017
Filing Date
2004-02-20
Accepted
2004-02-20 16:03:26
Documents
1
Period of Report
2004-02-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5944
  Complete submission text file 0000891293-04-000017.txt   7535
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
ASELAGE STEVE (Reporting) CIK: 0001221599 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 04619413